Ayuda
Ir al contenido

Dialnet


Caracterización de microbiota fecal en pacientes con síndrome de sjogren primario y su relación con la permeabilidad intestinal e inflamación

  • Autores: Antonio Cano Ortiz
  • Directores de la Tesis: María Isabel Queipo Ortuño (dir. tes.), Alberto Membrillo del Pozo (dir. tes.)
  • Lectura: En la Universidad de Córdoba (ESP) ( España ) en 2022
  • Idioma: español
  • Tribunal Calificador de la Tesis: Ignacio Jiménez Alfaro (presid.), Fernando Labella Quesada (secret.), Ana María Boto de los Bueis (voc.)
  • Programa de doctorado: Programa de Doctorado en Biociencias y Ciencias Agroalimentarias por la Universidad de Córdoba
  • Materias:
  • Enlaces
    • Tesis en acceso abierto en: Helvia
  • Resumen
    • 1. Introducción o motivación de la tesis El síndrome de Sjögren (SS) es una enfermedad de tipo autoinmune con importante afectación ocular. Su etiología es aún desconocida con un número de factores elevados como posibles generadores de la enfermedad. El cambio en la microbiota intestinal ha sido reportado como un factor diferencial entre los sujetos sanos y los sujetos con SS. Diferencias en la microbiota intestinal han sido reportantadas en otras patologías sistémicas autoinmunes.

      Para no tener factores de confusión entre otras patologías sistémicas autoinmunes se ha realizado un estudio en pacientes estrictamente seleccionados y con ausencia de otras alteraciones inmunitarias, siendo seleccionados sólo los pacientes con síndrome de Sjögren primario (SSP).

      Los objetivos de esta tesis doctoral han sido la caracterización de microbiota fecal en pacientes con SSP comparados con pacientes sanos, la determinación de parámetros inflamatorios en plasma de pacientes con SSP comparados con pacientes sanos y su relación con microbiota fecal, así como la determinación de permeabilidad intestinal a través de zonulina plasmática.

      2. Contenido de la investigación En esta tesis doctoral se ha realizado un estudio de pacientes con SSP para poder establecer si los cambios en la microbiota intestinal son asociados a la presencia de esta enfermedad de forma aislada, o bien si en el SSP no existen diferencias con los sujetos sanos. De este modo podríamos centrar investigaciones posteriores en otras patologías autoinmunes como la artirtis reumatoide (AR) y el lupus eritematosis sistémico (LES), entre otras. Algunos autores han estudiado patologías autoinmunes encontrando diferencias en la microbiota intestinal lo que nos ha llevado a profundizar en el estudio del SSP como entidad aislada sin otras enfermedades autoinunes asociadas que nos lleven a posibles confusiones.

      Se han estudiado parámetros de inflamación y de permeabilidad intestinal para intentar establecer relaciones entre estos parámetros y los cambios de la microbiota intestinal, así como se ha intentado establecer o aportar información sobre la etiopatogenia de la enfermedad.

      3. Conclusión Los resultados obtenidos muestran que la microbiota intestinal de los pacientes con SSP difieren tanto a nivel taxonómico como a nivel funcional con respecto a controles sanos. El perfil de microbiota intestinal de nuestros pacientes con SSP presentó una menor diversidad y riqueza siendo el filo Bacteroidetes el grupo más representado Se ha encontrado un aumento de la producción de citoquinas proinflamatorias y la disminución de la liberación de citoquinas antiinflamatorias (IL-10). Se necesitan más estudios para comprender mejor la realidad del impacto de la disbiosis en el curso del SSP y para concebir estrategias preventivas o terapéuticas para contrarrestar la inflamación impulsada por el microbioma.

      4. Bibliografía Abdelhamid L, Luo XM. Retinoic Acid, Leaky Gut, and Autoimmune Diseases. Nutrients. 2018;10(8):1016.

      Aderem A, Ulevitch RJ. Toll‐like receptors in the induction of the innate immune response. Nature 2000; 406:782-787 Acharya A, Chan Y, Kheur S, Jin LJ, Watt RM, Mattheos N. Salivary microbiome in non-oral disease: A summary of evidence and commentary. Arch Oral Biol. 2017; 83: 169–173. https://doi.org/10.1016/j.archoralbio.2017.07.019 PMID: 28780386 Aho K, Koskenvuo M, Tuominen J, Kaprio J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986; 13: 899–902.

      André R, Becker M, Lombardi T, Buchholzer S, Marchal F, Seebach JD. Comparison of Clinical Characteristics and Magnetic Resonance Imaging of Salivary Glands With Magnetic Resonance Sialography in Sjögren's Syndrome. Laryngoscope. 2021 Jan;131(1):E83-E89. doi: 10.1002/lary.28742. Epub 2020 May 15. PMID: 32413167.

      Akira S, Takeda K. Toll like receptor signaling. Nat Rev Immunol 2004; 4:499-511 Akpek EK, Mathews P, Hahn S, Hessen M, Kim, Grader-Beck T, Birnbaum J, Baer A. Ocular and systemic morbidity in a longitudinal cohort of Sjögren’s syndrome. Ophthalmology. 2015;122(1):56-61 
 Allali I, Arnold JW, Roach J, Cadenas MB, Butz N, Hassan HM, et al. A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome. BMC Microbiol. 2017; 17: 194S Alfonso AA, Monroy D, Stern ME, Feuer WJ, Tseng SC, Pflugfelder SC. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology. 1999 Apr;106(4):803-10. doi: 10.1016/S0161-6420(99)90170-7. PMID: 10201606.

      Alpan O, Bachelder E, Isil E, Arnheiter H, Matzinger P. Educated dendritic cells act as messengers from menor to naïve T helper cells. Nat Immunology 2004; 5:615-622 Alpaugh MA, Tam EM. Antibodies to cellular antigens in SjUgren syndmme.J Clin Invest 1975; 55: 1067.

      Alspaugh MA, Maddison P. Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematous and Sjögren's syndromme: an interlaboratory collaboration .Arthr Rheum 1979;22 796 Almståhl A, Wikström M, Stenberg I, Jakobsson A, Fagerberg-Mohlin B. Oral microbiota associated with hyposalivation of diferent origins. Oral Microbiol Immunol 2003; 18:1–8. doi:10.1034/j.1399-302X.2003.180101.x Amezcua-Guerra LM, Hofmann F, Vargas A, et al. Joint involvement in primary Sjögren's syndrome: an ultrasound "target area approach to arthritis". Biomed Res Int 2013; 2013:640265.

      Artis, D. (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8,411–420 Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, Onoue M, Yagita H, Ishii N, Evans R, Honda K, Takeda K. ATP drives lamina propria TH17 cell differentiation. Nature 2008; 455, 808–812 Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. 
Science 2011;331:337–41. doi:10.1126/science.1198469 
 Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa HT, et al. 
Treg induction by a rationally selected mixture of Clostridia strains from the 
human microbiota. Nature 2013; 500:232–6. doi:10.1038/nature12331 Aung W, Yamada I, Umehara I, Ohbayashi N, Yoshino N, Shibuya H. Sjögren's syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography. J Nucl Med. 2000 Feb;41(2):257-62. PMID: 10688108.

      Bäckhed F. Programming of host metabolism by the gut microbiota. Annals of Nutrition and Metabolism 2011; 58: 44-52 Baer AN, Medrano L, McAdams-DeMarco M, Gniadek TJ. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort. Arthritis Care Res (Hoboken) 2016; 68:1554.

      Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885.

      Berguiga M, Mameletzi E, Nicolas M, Rivier D, Majo F. Long-term follow-up of multilayer amniotic membrane transplantation (MLAMT) for non-traumatic corneal perforations or deep ulcers with descemetocele. Klin Monbl Augenheilkd. 2013 Apr;230(4):413-8. doi: 10.1055/s-0032-1328394. Epub 2013 Apr 29. PMID: 23629794.

      Bhute S, Pande P, Shetty SA, Shelar R, Mane S, Kumbhare SV, et al. Molecular characterization and meta-analysis of gut microbial communities illustrate enrichment of prevotella and Megasphaera in Indian subjects. Front Microbiol. 2016; 7: 660-674.

      Bian F, Barbosa FL, Corrales RM, Pelegrino FS, Volpe EA, Pflugfelder SC, de Paiva CS. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome. Arthritis Res Ther. 2015 Mar 10;17(1):53. doi: 10.1186/s13075-015-0582-9. PMID: 25889094; PMCID: PMC4392623.

      Bianciardi G, Latronico ME, Traversi C. Entropy of corneal nerve fibers distribution observed by laser scanning confocal microscopy: A noninvasive quantitative method to characterize the corneal innervation in Sjögren’s syndrome patients. Microsc Res Tech. 2015;78(12):1069e74 Bilsborough J, Viney JL. Gastrointestinal dendritic cells play a role in immunity, tolerance and disease. Gastroenterology 2004;127:300‐309 Birnbaum J, Peripheral nervous system manifestations of Sjögrensyndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist.2010;16(5): 287–297https://doi.org/10.1097/NRL.0b013e3181ebe59f Brauner S, Folkersen L, Kvarnström M, Meisgen S, Petersen S, Franzén-Malmros M, Mofors J, Brokstad KA, Klareskog L, Jonsson R, Westerberg LS, Trollmo C, Malmström V, Ambrosi A, Kuchroo VK, Nordmark G, Wahren-Herlenius M. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production. Ann Rheum Dis. 2017 Oct;76(10):1755-1763. doi: 10.1136/annrheumdis-2016-210509. Epub 2017 Jul 31. PMID: 28760805; PMCID: PMC5629946.

      Brito Zeron P, Kostov BA, Zeher M et al (2015) OP0089 Big Data Sjögren Project (Eular-SS Task Force International Network): characterization at Diagnosis of 5027 patients with primary Sjögren syndrome. Ann Rheum Dis 74 (Suppl 2): 102. https://doi.org/10.1136/annrheumdis-2015-eular.4035 Bodewes ILA, Al-Ali S, van Helden-Meeuwsen CG, Maria NI, Tarn J, Lendrem DW, Schereurs MWJ, Steenwijk EC, van Daele PLA, Both T, Bowman SJ, Griffiths B, Wan-Fai, Versnel MA.Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity. Rheumatology (Oxford) 2018; 57: 921–30.

      Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature Biotechnology. 2019; 37: 852-857 Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S33-40. doi: 10.1016/j.jaci.2009.09.017. Epub 2010 Jan 12. PMID: 20061006.

      Botsios C, Furlan A, Ostuni P, et al. Elderly onset of primary Sjögren's syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 2011; 78:171.

      Bournia VK, Diamanti KD, Vlachoyiannopoulos PG, Moutsopoulos HM. Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis. Arthritis Res Ther 2010; 12:R47.

      Bouskra D, Brezillon C, Bérard M, Werst C, Varona R, Boneca G, Eberl G.Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008; 456, 507–510 Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjögren’s syndrome using a new questionnaire tool. Rheumatology (Oxford) 2004; 43: 758–64. 
 Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 2007; 204: 1891–1900 Brito-Zerón P, Kostov B, Solans R, Fraile G, Suárez-Cuervo C, Casanovas A, Rascón FJ, Qanneta R, Pérez-Alvarez R, Ripoll M, Akasbi M, Pinilla B, Bosch JA, Nava-Mateos J, Díaz-López B, Morera-Morales ML, Gheitasi H, Retamozo S, Ramos-Casals M. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis 2016; 75: 348–55.

      Brito-Zerón P, Acar-Denizli N, Zeher M, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis 2017; 76:1042.

      Brkic Z, Naomi IM, van Helden-Meeuwsen CG, van de Merwe JP, van Daele PL, Dalm VA, Wildenberg ME, Beumer W, Drexhage HA, Versnel MA .Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren’s syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis 2013; 72: 728–35.

      Brocker C, Thompson D, Matsumoto A, Nebert D, Vasiliou V.Evolutinoary divergence and functions of the human interleukin(IL) gene family.Human Genomics 5(1) 30-55. ISSN 14739542. PMC 3390169.PMDI21106488.doi:10.1186/1479-7364-5-1-30.

      Brownlee M, Knight J, Dettmar PW, Pearson JP: Action of reactive oxygen species on colonic mucus secretions. Free Radic Biol Med 2007, 43:800–808.

      Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA. TFOS DEWS II pathophysiology report. Ocul Surf. 2017 Jul;15(3):438-510. doi: 10.1016/j.jtos.2017.05.011. Epub 2017 Jul 20. Erratum in: Ocul Surf. 2019 Oct;17(4):842. PMID: 28736340.

      Burbelo PD, Ferré EMN, Chaturvedi A, et al. Profiling Autoantibodies against Salivary Proteins in Sicca Conditions. J Dent Res 2019; 98:772.

      Burke C, Steinberg P, RuschD, Kjelleberg S, Thomas T. Bacterial community assembly based on functional genes rather than species. Proc. Natl. Acad. Sci. USA 2011; 108:14288–14293 Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 2015; 11: 577–91.

      Carrozzo M. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma. Oral Dis 2008; 14:123.

      Chan EK, Hamel JC, Buyon JP, Tan EM. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 1991; 87:68.

      Chao, A. 1984. Non-parametric estimation of the number of classes in a population. Scandinavian Journal of Statistics 11, 265-270 Chao WC, Lin CH, Liao TL, Chen YM, Chen DY, Chen HH. Association between a history of mycobacterial infection and the risk of newly diagnosed Sjogren’s syndrome: a nation- wide, population-based case-control study. PLoS ONE 2017; 12: e0176549.

      Chen YI, Nikulina K, Lazarev S, Bahrami AF, 
Noble LB, Gallup M and McNamara NA. Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren’s syndrome. Am J Pathol. 2010;177(3):1333e43 Chen J, Vitetta L. The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation. Immune Netw. 2020;20(2): e15.

      Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010; 17:303.

      Christina Tsigalou, Elisavet Stavropoulo, Eugenia Bezirtzoglou. Current insights in Microbiome Shifts in Sjögren’s Syndrome and Possible Therapeutic interventions. Frontiers in Immunology 2018 doi: 10.3389/ mmu.2018.01106 Christodoulou MI, Kapsogeorgou EK ,Moutsopoulos H.M. Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome, J. Autoimmun. 34 (2010) 400–407.

      Clarke, TB, Davis KM, Lysenko ES, Zhou AY, Yu Y and Weiser JN .Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010;16, 228–231 Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn´s disease. Immunol Rev 2005; 206:277-295 Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42:D633-42.

      Coursey TG, Bohat R, Barbosa FL, Pflugfelder SC, de Paiva CS. Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye. J Immunol. 2014 Nov 15;193(10):5264-72. doi: 10.4049/jimmunol.1400016. Epub 2014 Oct 6. PMID: 25288568; PMCID: PMC4225173.

      Coursey TG, Bian F, Zaheer M, Pflugfelder SC, Volpe EA, de Paiva CS. Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells. Mucosal Immunol. 2017 May;10(3):743-756. doi: 10.1038/mi.2016.83. Epub 2016 Oct 5. PMID: 27706128; PMCID: PMC5380589.

      Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001; 345:340.

      De La Cuesta-Zuluaga, J.; Kelley, S.T.; Chen, Y.; Escobar, J.S.; Mueller, N.T.; Ley, R.E.; McDonald, D.; Huang, S.;Swa_ord, A.D.; Knight, R.; et al. Age- and Sex-Dependent Patterns of Gut Microbial Diversity in Human Adults. mSystems 2019, 4, e00261-19.

      Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984; 27:147.

      De Oliveira, G., Leite, A. Z., Higuchi, B. S., Gonzaga, M. I., & Mariano, V. S. Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology, 2017;152(1):1–12.

      De Paiva CS, Villarreal AL, Corrales RM, Rahman HT, Chang VY, Farley WJ, Stern ME, Niederkorn JY, Li DQ, Pflugfelder SC. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2553-60. doi: 10.1167/iovs.07-0069. PMID: 17525184.

      De Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, Streckfus CF, Hutchinson DS, Ajami NJ, Petrosino JF, Pflugfelder SC. Altered mucosal microbiome diversity and disease severity in Sjögren Syndrome. Sci Rep 2016; 6: 23561.

      De Paiva CS, Pflugfelder SC, Ng SM, Akpek EK. Topical cyclosporine A therapy for dry eye syndrome. Cochrane Database Syst Rev 2019; 9:CD010051.

      Earle K.A., Billings G., Sigal M., Lichtman J.S., Hans-son G.C., Elias J.E., Amieva M.R., Huang K.C., Sonnenburg J.L. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe. 2015;18:478–488.

      Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol 2012; 46:25.

      Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human in- testinal microbial flora. Science 2005; 308: 1635–1638.

      Ekström Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111:4029.

      Ellis GL. Lymphoid lesions of salivary glands: malignant and benign. Med Oral Patol Oral Cir Bucal 2007; 12:E479.

      Erkelens MN, Mebius RE. Retinoic Acid and Immune Homeostasis: A Balancing Act. Trends Immunol. 2017; 38(3):168-180.

      Esquivel-Elizondo, S.; Ilhan, Z.E.; Garcia-Peña, E.I.; Krajmalnik-Brown, R. Insights into Butyrate Production in a Controlled Fermentation System via Gene Predictions. mSystems 2017, 2, e00051-17.

      Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002; 298:1414‐1427 Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91(1):151–75 Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci. 1997 Apr; 42(4):817-22.

      Feinstein AJ, Ciarleglio MM, Cong X, et al. Parotid gland lymphoma: prognostic analysis of 2140 patients. Laryngoscope 2013; 123:1199.

      Fernando MR, Saxena A, Reyes JL, McKay DM (2016) Butyrate enhances antibacterial effects while suppressing other features of alternative activation in IL-4-induced macrophages. Am J Physiol-Gastr L 310(10): G822–G831.

      Ferro F, Marcucci E, Orlandi M, Baldini C, Bartoloni-Bocci E. One year in review 2017: primary Sjögren’s syndrome. Clin Exp Rheumatol 2017; 35(2):179–91.

      Fisher BA, Jonsson R, Daniels T, et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome. Ann Rheum Dis 2017; 76:1161.

      Foulks GN. Treatment of dry eye disease by the non-ophthalmologist. Rheum Dis Clin North Am 2008; 34:987.

      Franceschini F, Cavazzana I, Andreoli L, Tincani A. The 2016 classification criteria for primary Sjögren’s syndrome: what’s new. BMC Med 2017; 15-69.

      Fricker A.M., Podlesny D., Fricke W.F. What is new and relevant for sequencing-based microbiome research? A mini-review. J. Adv. Res. 2019;19:105–112.

      Gaboriau-Routhiau V, Cerf-Bensussan N. Microbiote intestinal et développement du système immunitaire [Gut microbiota and development of the immune system]. Med Sci (Paris). 2016 Nov;32(11):961-967. French. doi: 10.1051/medsci/20163211011. Epub 2016 Dec 23. PMID: 28008836.

      Geuking MB, Cahen zli J, Lawson MA: Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011, 34:794–806.

      Ghrenassia E, Martis N, Boyer J, et al. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review. J Autoimmun 2015; 59:19.

      Gooding JM, Yap KL, Ikura M: The cadherin-catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. BioEssays 2004; 26:497–511.

      Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, Mariette X. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome. Proc Natl Acad Sci USA 2006; 103: 2770–5.

      Greiling TM, Dehner C, Chen X, Hughes K, Iñiguez AJ, Boccitto M, Ruiz DZ, Renfroe SC, Vieira SM, Ruff WE, Sim S, Kriegel C, Glanternik J, Chen X, Girardi M,
 Degnan P, Costenbader KH, Goodman AL, Wolin SL, Kriegel MA. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med 2018; 10: eaan2306.

      Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 2001; 108:936.

      Hall DM, Buettner GR, Oberley LW, Xu L, Matthes RD, Gisolfi CV: Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia. Am J Physiol Heart Circ Physiol 2001; 280:H509–H521 Hall JC, Baer AN, Shah AA, Criswell LA, Shiboski CH, Rosen A, Casciola-Rosen L. Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome. Arthritis Rheumatol. 2015 Sep;67(9):2437-46. doi: 10.1002/art.39204. PMID: 25988820; PMCID: PMC4551661.

      Hao WL, Lee YK. Microflora of the gastrointestinal tract; A review. Methods Mol Biol 2004; 268:491-502 Harley JB, Sestak AL, Willis LG, et al. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum 1989; 32:826.

      Heverhagen JT, Kalinowski M, Rehberg E, Klose KJ, Wagner HJ. Prospective comparison of magnetic resonance sialography and digital subtraction sialography. J Magn Reson Imaging. 2000 May;11(5):518-24. doi: 10.1002/(sici)1522-2586(200005)11:5<518::aid-jmri7>3.0.co;2-5. PMID: 10813861.

      Hevia, C. Milani, P. López, A. Cuervo, S. Arboleya, S. Duranti, et al., Intestinal dysbiosis associated with systemic lupus erythematosus, mBio 5 (2014) e01548-14.

      Hirai N, Kawasaki S, Tanioka H, Connon CJ, Yamasaki K, Yokoi N, Komuro A, Kinoshita S. Pathological keratinisation in the conjunctival epithelium of Sjögren's syndrome. Exp Eye Res. 2006 Mar;82(3):371-8. doi: 10.1016/j.exer.2005.07.009. Epub 2005 Sep 6. PMID: 16143330.

      Holland EJ, Mannis MJ, Lee WB. The Tear Film: Anatomy, Structure and Function. In: Holland EJ, Mannis MJ (eds) Lee WB: Ocular Surface Disease: Cornea, Conjunctiva and Tear film. London, Elsevier Health Sciences; 2013
 Holland EJ, Whitley WO, Sall K, et al. Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials. Curr Med Res Opin 2016; :1.

      Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature 2016; 535: 75–84.

      Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI: Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291: 881–884.

      Hsi ED, Zukerberg LR, Schnitzer B, Harris NL. Development of extrasalivary gland lymphoma in myoepithelial sialadenitis. Mod Pathol 1995; 8:817.

      Hyphantis T, Mantis D, Voulgari PV, Tsifetaki N, Drosos AA. The psychological defensive profile of primary Sjögren’s syndrome patients and its relationship to health-related quality of life. Clin Exp Rheumatol 2011; 29: 485–93.

      Iljazovic, A.; Roy, U.; Gálvez, E.J.C.; Lesker, T.R.; Zhao, B.; Gronow, A.; Amend, L.; Will, S.E.; Hofmann, J.D.;Pils, M.C.; et al. Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility tomucosal inflammation. Mucosal I mmunol. 2020, 1–12.

      Imanguli MM, Atkinson JC, Mitchell SA, et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant 2010; 16:1362.

      Ivanov II, Frutos R de L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR: Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008; 4:337–349.

      Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal 17 cells by segmented lamentous bacteria. Cell 2009; 139:485–98.

      Jabs DA, Prendergast RA, Rorer EM, Hudson AP, Whittum-Hudson JA. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2567-71. PMID: 11581200.

      Jackson DC, Zeng W, Wong CY, Mifsud EJ, Williamson NA, Ang CS, Vingrys AJ, Downie LE. Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4824-4830. doi: 10.1167/iovs.16-19757. PMID: 27654409.

      Jang MH, Kweon MN, Iwatani K, Yamamoto M, Terahara K,
 Sasakawa C, Suzuki T, Nochi T, Yokota Y, Rennert PD, Hiroi T, Tamagawa H, Iijima H, Kunisawa J, Yuki Y, Kiyono H. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA 2004; 101:6110-6115 Jonsson R, Theander E, Sjostrom B, Brokstad K, Henriksson G. Autoantibodies present before symptom onset in primary Sjögren syndrome. JAMA 2013; 310: 1854–5.

      Jousse-Joulin S, Nowak E, Cornec D, Brown J, Carr A, Carotti M, Fisher B, Fradin J, Hocevar A, Jonsson MV, Luciano N, Milic V, Rout J, Theander E, Stel A, Bootsma H, Vissink A, Baldini C, Baer A, Ng WF, Bowman S, Alavi Z, Saraux A, Devauchelle-Pensec V. Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliability. RMD Open. 2017 Jun 9;3(1):e000364. doi: 10.1136/rmdopen-2016-000364. PMID: 28879042; PMCID: PMC5575597.

      Jovel J., Patterson J., Wang W., Hotte N., O’Keefe S., Mitchel T., Perry T., Kao D., Mason A.L., Madsen K.L., et al. Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics. Front. Microbiol. 2016;7:459.

      Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013; 14: 685–90.

      Kawasaki S, Kawamoto S, Yokoi N, Connon C, Minesaki Y, Kinoshita S, Okubo K. Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome. Exp Eye Res. 2003 Jul;77(1):17-26. doi: 10.1016/s0014-4835(03)00087-3. PMID: 12823984.

      Kazi S, Cohen PR, Williams F, et al. The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. AIDS 1996; 10:385.

      Kim J, Sun D, Ozl R, et al. A validated method of labial minor salivary gland biopsy for the diagnosis of Sjögren's syndrome. Laryngoscope 2016; 126:2041.

      Kittridge A, Routhouska SB, Korman NJ. Dermatologic manifestations of Sjögren syndrome. J Cutan Med Surg 2011; 15:8.

      Kobayashi, K.S, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nuñez G, Flavell RA. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307, 731–734 Kostic A, Gevers D,Siljander H,Vatanen T,Hyötyläinen T,Hämäläinen A,Peet A,Tillmann V,Pöhö P,Mattila I,Lähdesmäki H,Franzosa E,Vaarala O,De Goffau M,Harmsen H,Ilonen J,Virtanen S,Clish C,Orešič M,Huttenhower C,Knip M,Xavier R for the DIABIMMUNE Study Group. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 2015; 17: 260–73.

      Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D: Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad 2011; 108:11548–11553.

      Kvarnstrom M, Ottosson V, Nordmark B, Wahren-Herlenius M. Incident cases of primary Sjögren’s syndrome during a 5- year period in Stockholm County: a descriptive study of the patients and their characteristics. Scand J Rheumatol 2015; 44: 135–42.

      Lanning DK, Rhee KJ. Intestinal bacteria and development of the B-lymphocyte repertoire. Trends Immunol 2005; 26:419‐425 Lessard CJ, Li H, Adrianto I et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome. Nat Genet 2013; 45: 1284–92.

      Lewis K, Lutgendorff F, Phan V, Söderholm JD, Sherman PM, McKay DM: Enhanced Translocation of Bacteria Across Metabolically Stressed Epithelia is Reduced by Butyrate. Inflammatory Bowel Diseases 2010; 16:1138–1148.

      Le Chatelier E., T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, G. Falony, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-546.

      Li B, Selmi C, Tang R, Gershwin ME, Ma X. The microbiome and autoimmunity: a paradigm from the gut-liver axis. Cell Mol Immunol. 2018 Jun;15(6):595-609. doi: 10.1038/cmi.2018.7. Epub 2018 Apr 30. PMID: 29706647; PMCID: PMC6079090.

      Li M, Zou Y, Jiang Q, Jiang L, Yu Q, Ding X, Yu Y.A preliminary study of the oral microbiota in Chinese patients with Sjögren’s syndrome. Arch Oral Biol 2016; 70: 143–8.

      Liew MS, Zhang M, Kim E, Akpek EK. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol 2012; 96:1498.

      Liu SY, Vlantis AC, Lee WC. Bilateral parotid and submandibular gland enlargement: rare features of Wegener's granulomatosis. J Laryngol Otol 2003; 117:148.

      Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin beta receptor, and TNF receptor I function. J Immunol. 2003;170(11):5475-82.

      Louis, P.; Flint, H.J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 2017, 19, 29–41.

      Lourenco TG, Heller D, Silva-Boghossian CM, Cotton SL, Paster BJ, Colombo AP.Microbial signature profiles of periodontally healthy and diseased patients. J Clin Periodontol. 2014; 41: 1027–1036. https://doi.org/10.1111/jcpe.12302 PMID: 25139407 Lu M-C, Jheng C-H, Tsai T-Y, Koo M, Lai N-S. Increased dental visits in patients prior to diagnosis of primary Sjögren’s syndrome: a population-based study in Taiwan. Rheumatol Int 2014; 34:1555–61.

      Luni FK, Malik SA, Khan AR, et al. Risk of Ischemic Heart Disease in Patients With Sjögren's Syndrome. Am J Med Sci 2017; 354:395.

      Lukumbuzya M., Schmid M., Pjevac P., Daims H.A. Multicolor Fluorescence in situ Hybridization Approach Using an Extended Set of Fluorophores to Visualize Microorganisms. Front. Microbiol. 2019;10:1383.

      Lynch DA. Lung disease related to collagen vascular disease. J orac Imaging 2009; 24(4): 299–309.

      Ma Q, Song H. Diagnosis and management of lymphoepithelial lesion of the parotid gland. Rheumatol Int 2011; 31:959.

      Ma CS, Wong N, Rao G, Avery DT, Torpy J, Hambridge T, Bustamante J, Okada S, Stoddard JL, Deenick EK, Pelham SJ, Payne K, Boisson-Dupuis S, Puel A, Kobayashi M, Arkwright PD, Kilic SS, El Baghdadi J, Nonoyama S, Minegishi Y, Mahdaviani SA, Mansouri D, Bousfiha A, Blincoe AK, French MA, Hsu P, Campbell DE, Stormon MO, Wong M, Adelstein S, Smart JM, Fulcher DA, Cook MC, Phan TG, Stepensky P, Boztug K, Kansu A, İkincioğullari A, Baumann U, Beier R, Roscioli T, Ziegler JB, Gray P, Picard C, Grimbacher B, Warnatz K, Holland SM, Casanova JL, Uzel G, Tangye SG. Monogenic mutations differentially affect the 
quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies, J. Allergy Clin. Immunol. 136 (4)2015;993–1006.

      Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. Ophthalmology 1999; 106:811.

      McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012 Mar;6(3):610-8.

      Maciel G, Crowson CS, Matteson EL, Cornec D. Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort. Mayo Clin Proc 2017; 92:734.

      Maldini C, Seror R, Fain O, et al. Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area. Arthritis Care Res (Hoboken) 2014; 66:454.

      Mandl T, Marsal J, Olsson P, Ohlsson B, Andreasson K. Severe intestinal dysbiosis is prevalent in primary Sjögren’s syndrome and is associated with systemic disease activity. Arthritis Res Ther 2017; 19: 237.

      Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, Costa FRC, Tiniakou E, Greiling T, Ruff W, Barbieri A, Kriegel C, Mehta SS, Knight JR, Jain D, Goodman AL, Kriegel MA. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 2018; 359: 1156–61.

      Mariette X, Criswell LA. Primary Sjögren’s syndrome. N Engl J Med 2018; 378: 931–9 Mark DP Willcox, Pablo Argüeso, Georgi A. Georgi A Georviev, Juha M. Holopainen, Gordon W. Laurie, Tom J. Millar, Eric B. Papas, Jannick P. Rolland, Tannin A. Schmidt, Ulrike Stahl, Tatiana Suarez, Lakshman N. Subbaraman, Optom, Omür O. Uçakhan, Lyndon Jones.TFOS DEWS II Tear Film Report. The Ocular Surface 15 2017; 366-403.

      Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013; 339: 1084–8.

      Masui R, Sasaki M, Funaki Y, Ogasawara N, Mizuno M, Iida A, Izawa S, Kondo Y, Ito Y, Tamura Y, Yanamoto K, Noda H, Tanabe A, Okaniwa N, Yamaguchi Y, Iwamoto T, Kasugai K. G protein-coupled receptor 43 moderates gut inflam- mation through cytokine regulation from mononuclear cells. Inflamm Bowel Dis 2013;19(13):2848–2856. Mathews PM, Hahn S, Hessen M, Kim J, Grader-Beck T, Birnbaum J, Baer AN, Akpek EK. Ocular complications of primary Sjögren syndrome in men. Am J Ophthalmol. 2015;160(3):447e5 Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL: An immunomodulatory mole- cule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107–118.

      Mazmanian SK, Round JL, Kasper DL: A microbial symbiosis fact or prevents intestinal inflammatory disease. Nature 2008; 453:620–625.

      Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106:255-258 Mendez, R., Watane, A., Farhangi, M. et al. Gut microbial dysbiosis in individuals with Sjögren’s syndrome. Microb Cell Fact 2020;19: 90.

      Menéndez A, Gómez J, Escanlar E, et al. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection. Autoimmunity 2013; 46:32.

      Meng ID, Kurose M. The role of corneal afferent neurons in regulating tears under normal and dry eye conditions. Exp Eye Res. 2013; 117:79e87 Meng Z, Klinngam W, Edman MC, Hamm-Alvarez SF. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome. PLoS One. 2017 Sep 13;12(9):e0184781. doi: 10.1371/journal.pone.0184781. PMID: 28902875; PMCID: PMC5597228.

      Menzies KL, Srinivasan S, Prokopich CL, Jones L. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren’s syndrome patients and nondry eye controls. Invest Ophthalmol Vis Sci. 2015; 56(2):836e41 Milic VD, Petrovic RR, Boricic IV, Marinkovic-Eric J, Radunovic GL, Jeremic PD, Pejnovic NN, Damjanov NS. Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjogren's syndrome: a comparison with scintigraphy and biopsy. J Rheumatol. 2009 Jul;36(7):1495-500. doi: 10.3899/jrheum.081267. Epub 2009 Jun 1. PMID: 19487274.

      Mofors J, Arkema EV, Björk A, Westermark L, Kvarnström M, Forsblad-d’Elia H, Bucher SM, Eriksson P, Mandl T, Nordmark G, Wahren-Herlenius M. Infections increase the risk of developing Sjögren’s syndrome. J Intern Med 2019; 285: 670–80.

      Moon J, Choi SH, Yoon CH, Kim MK. Gut dysbiosis is prevailing in Sjögren's syndrome and is related to dry eye severity. PLoS One. 2020;15(2):e0229029.

      Moreno C . M&T – Manuales y Tesis SEA, vol. 1.Primera Edición: 2001Título del volumen: Métodos para medir la biodiversidad ISSN (colección): 1576 – 9526 ISBN (volumen): 84 – 922495 – 2 – 8 Depósito Legal: Z– 2655 – 2000.

      Morgan WS, Castleman B. A clinicopathologic study of mikulicz's disease. Am j pathol 1953; 29:471.

      Mossel E, Delli K, van Nimwegen JF, Stel AJ, Kroese FGM, Spijkervet FKL, Vissink A, Arends S, Bootsma H; EULAR US-pSS Study Group. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren's syndrome. Ann Rheum Dis. 2017 Nov;76(11):1883-1889. doi: 10.1136/annrheumdis-2017-211250. Epub 2017 Jul 28. PMID: 28754802.

      Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD: The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010, 6:392–405.

      Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L,
 Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H. Human blood CXCR5(+) CD4(+) T 
cells are counterparts of T follicular cells and contain specific subsets that differ- 
entially support antibody secretion, Immunity 34 (1) 2011; 108–121. 
 Nagler‐Anderson C. Man the barrier! Strategic defences in the intestinal mucosa. Nat Rev Immunol 2001;1:59-67 Neu J, Lorca G, Kingma SDK, Triplett EW: The Intestinal Microbiome: Relationship to Type 1. Diabetes 2010, 39:563–571.

      Niemelä RK, Pääkkö E, Suramo I, Takalo R, Hakala M. Magnetic resonance imaging and magnetic resonance sialography of parotid glands in primary Sjogren's syndrome. Arthritis Rheum. 2001 Dec;45(6):512-8. doi: 10.1002/1529-0131(200112)45:6<512::aid-art376>3.0.co;2-r. PMID: 11762685.

      Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nat Rev Rheumatol. 2013 Sep;9(9):544-56. doi: 10.1038/nrrheum.2013.110. Epub 2013 Jul 16. PMID: 23857130.

      Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol 2015; 168:317.

      Nordmark, G.; Kristjansdottir, G.; Theander, E.; Eriksson, P.; Brun, J.G.;Wang, C.; Padyukov, L.; Truedsson, L.; Alm, G.; Eloranta, M.L.; et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren’s syndrome. Genes. Immun. 2009, 10, 68–76) Ogawa Y, Kuwana M, Yamazaki K, Mashima Y, Yamada M, Mori T, Okamoto S, Oguchi Y, Kawakami Y. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci. 2003 May;44(5):1888-96. doi: 10.1167/iovs.02-0699. PMID: 12714620.

      Ogawa Y, Yamazaki K, Kuwana M, Mashima Y, Nakamura Y, Ishida S, Toda I, Oguchi Y, Tsubota K, Okamoto S, Kawakami Y. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci. 2001 Jan;42(1):111-9. PMID: 11133855.

      Ohland CL, MacnaughtonWK: Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 2010; 298:G807–G819.

      Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM,
 Kasper DL, Blumberg RS. Microbial exposure during early life has persistent e ects on natural killer T cell function. Science 2012; 336:489–93. doi:10.1126/science.1219328 Omenetti S, Pizarro TT. The Treg/Th17 axis: a dynamic balance regulated by the gut microbiome. Front Immunol 2015; 6:639.

      Paassen BN, Vincent A, Puiman PJ, van der Sluis M, Bouma J, Boehm G, van Goudoever JB, van Seuningen I, Renes IB: The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J 2009; 420:211–219.

      Pawlina, Wojciech; Ross, Michael H. Spa-Ross histologia texto y at. ISBN 10: 8417602658 ISBN 13: 9788417602659 Editorial: LIPPINCOTT RAVEN, 2020 Peck AB, Nguyen CQ. What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome? Clin Immunol. 2017 Sep;182:14-23. doi: 10.1016/j.clim.2017.05.001. Epub 2017 May 3. PMID: 28478104; PMCID: PMC5763483.

      Per Brandtzaeg Immunological Investigations, 39:303–355, 2010 Copyright © Informa Health0131003680369 Percival RS, Challacombe SJ, Marsh PD. Flow rates of resting whole and stimulated parotid saliva in relation to age and gender. J Dent Res. 1994 Aug;73(8):1416-20. doi: 10.1177/00220345940730080401. PMID: 8083437.

      Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, Glöckner FO. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35(21):7188-96.

      Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 2015; 74: 1983–9.

      Quince C., Walker A.W., Simpson J.T., Loman N.J., Segata N. Shotgun metagenomics, from sampling to analysis. Nat. Biotechnol. 2017;35:833–844.

      Radfar L, Kleiner DE, Fox PC, Pillemer SR. Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum 2002; 47:520.

      Radjabzadeh, D.; Boer, C.G.; Beth, S.A.; Van Der Wal, P.; Jong, J.C.K.-D.; Jansen, M.A.E.; Konstantinov, S.R.;Peppelenbosch, M.P.; Hays, J.P.; Jaddoe, V.W.; et al. Diversity, compositional and functional diferences between gut microbiota of children and adults. Sci. Rep. 2020, 10, 1–13.

      Ramiro-Puig E, Pérez-Cano FJ, Castellote C, Franch A, Castell M. El intestino: pieza clave del sistema inmunitario [The bowel: a key component of the immune system]. Rev Esp Enferm Dig. 2008 Jan;100(1):29-34. Spanish. doi: 10.4321/s1130-01082008000100006. PMID: 18358058.

      Ramos-Casals M, García-Carrasco M, Brito MP, et al. Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly. Lupus 2003; 12:341.

      Ramos-Casals M, Brito-Zerón P, García-Carrasco M, Font J. Sarcoidosis or Sjögren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 2004; 83:85.

      Ramos-Casals M, Loustaud-Ratti V, De Vita S, et al. Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore) 2005; 84:81.

      Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, del Pino-Montes J, Calvo-Alen J, Jiménez-Alonso J, Micó ML, Beltrán J, Belenguer R, Pallarés L, and the GEMESS Study Group. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87(4):210e9 Rasmussen A, Stone DU, Kaufman CE, Hefner KS, Fram NR, Siatkowski RL, Huang AJW, Chodosh J, Rasmussen PT, Fife DA, Pezant N, Grundahl K, Radfar L, Lewis DM, Weisman MH, Venuturupalli S, Wallace DJ, Rhodus NL, Brennan MT, Montgomery CG, Lessard CJ, Scofield RH, Sivils KL. Reproducibility of Ocular Surface Staining in the Assessment of Sjögren Syndrome-Related Keratoconjunctivitis Sicca: Implications on Disease Classification. ACR Open Rheumatol. 2019 Jul;1(5):292-302. doi: 10.1002/acr2.1033. Epub 2019 Jun 7. PMID: 31453437; PMCID: PMC6710016.

      Retamozo S, Akasbi M, Brito-Zerón P, et al. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome. Clin Exp Rheumatol 2012; 30:686.

      Rocha EM, Alves M, Rios JD, Dartt DA. The aging lacrimal gland: changes in structure and function. Ocul Surf. 2008;6(4):162e74.
 Romero-Rangel T, Stavrou P, Cotter J, et al. Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol 2000; 130:25.

      Rook GA, Brunet LR: Microbes, immunoregulation, and the gut. Gut 2005; 54:317–320.

      Round, J. L., and Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2010; 107:12204–12209.

      Rúa Figueroa I, Calvo J, Cuadrado MJ, Freire MM, Martínez- Taboada VM, Muñoz S, Úcar E. Manual SER de diagnóstico y tratamiento de las enfermedades reumáticas autoinmunes sistémicas. 2014. Sociedad Española de Reumatología (SER). ISBN edición impresa: 978-84-9022-857-9 Rusthen S, Kristoffersen AK, Young A, Galtung HK, Petrovski BÉ, Palm Ø, Enersen M, Jensen JL. Dysbiotic salivary microbiota in dry mouth and primary Sjögren's syndrome patients. PLoS One. 2019 Jun 18;14(6):e0218319. doi: 10.1371/journal.pone.0218319. PMID: 31211815; PMCID: PMC6581286.

      Säemann MD, Böhmig GA, Osterreicher CH, Burtscher H, Parolini O, Diakos C, Stöckl J, Hörl WH, Zlabinger GJ. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. The FASEB Journal,2000; 14(15):2380–2382. Salvo-Romero Eloisa, Carmen Alonso-Cotoner, Cristina Pardo-Camacho, Maite Casado-Bedmar y María Vicario. Función barrera intestinal y su implicación en enfermedades digestivas Rev esp enferm dig Vol. 107, N.º 11, pp. 686-696, 2015 Sapone a. Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives. Diabetes. 2006; 55(5):1443–9 Scharschmidt TC, Vasquez KS, Truong HA, Gearty SV, Pauli ML, Nosbaum A, Gratz IK, Otto M, Moon JJ, Liese J, Abbas AK, Fischbach MA, Rosenblum MD.A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity 2015; 43:1011–21.

      Schwartz LM, Woloshin S. A Clear-eyed View of Restasis and Chronic Dry Eye Disease. JAMA Intern Med 2018; 178:181.

      Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41-101. doi: 10.1016/S0065-2776(07)96002-2. PMID: 17981204.

      Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 2009; 1165:294--‐300.

      Scott J. Qualitative and quantitative observations on the histology of human labial salivary glands obtained post mortem. J Biol Buccale 1980; 8:187.

      Serreze DV, Post CM, Chapman HD, Johnson EA, Lu B, Rothman PB: Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice. Diabetes 2000; 49:2007–2011 Shah D, Sah S, Nath SK. Interaction between glutathione and apoptosis in systemic lupus erythematosus. Autoimmun Rev. 2013;12(7):741-751.

      Shakya M., Lo C.C., Chain P.S.G. Advances and Challenges in Metatranscriptomic Analysis. Front. Genet. 2019;10:904.

      Sharma R, Zheng L, Guo X, Fu SM, Ju ST, Jarjour WN. Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient mice. J Autoimmun. 2006 Dec;27(4):289-296. doi: 10.1016/j.jaut.2006.11.003. Epub 2007 Jan 3. PMID: 17207605; PMCID: PMC3970716.

      Sharma D, Sandhya P, Vellarikkal SK, Surin AK, Jayarajan R, Verma A, Kumar A, Ravi R, Danda D, Sivasubbu S, Scaria V. Saliva microbiome in primary Sjögren's syndrome reveals distinct set of disease-associated microbes. Oral Dis. 2020 Mar;26(2):295-301. doi: 10.1111/odi.13191. Epub 2020 Jan 10. PMID: 31514257.

      Shen L, Suresh L, Lindemann M, et al. Novel autoantibodies in Sjogren's syndrome. Clin Immunol 2012; 145:251.

      Sheppard JD, Torkildsen GL, Geffin JA, et al. Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials. Ocul Surf 2019; 17:142.

      Sher J., Sczesnak A., Longman R., Segata N., Ubeda C., Bielski C., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013;2: e01202.

      Shiboski sc, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, Schidt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, Mcnamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan JS, Daniels TE.
American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care Res (Hoboken) 64: 475–487.

      Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X; International Sjögren's Syndrome Criteria Working Group. American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9-16 Siddiqui H, Chen T, Aliko A, Mydel PM, Jonsson R, Olsen I. 
Microbiological and bioinformatics analysis of primary Sjögren’s syndrome patients with normal salivation. J Oral Microbiol 2016; 8: 31119.

      Silman AJ, MacGregor AJ, Thomson W, HOLLIGAN S, CARTHY D, FARHAN A, OLLIER WER. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993; 32: 903–7.

      Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S, Ganapathy V. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014; 40(1):128-39. Singh R, Lei P, Andreadis ST: PKC-δ binds to E-cadherin and mediates EGF-induced cell scattering. Exp Cell Res 2009; 315:2899–2913.

      Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca. Acta Ophthalomol 1933; 11(suppl II):1.

      Slack E, Hapfelmeier S, Stecher B, Velykored- ko Y, Stoel M, Lawson MA, Geuking MB, Beutler B, Tedder TF, Hardt WD, Bercik P, Verdu EF, McCoy KD, Macpherson AJ: In- nate and adaptive immunity cooperate flex- ibly to maintain host-microbiota mutualism. Science 2009; 325: 617–620 Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008; 105:16731-36.

      Spalding MD, Prigge ST. Lipoic acid metabolism in microbial pathogens. Microbiol Mol Biol Rev. 2010;74(2):200-228.

      Stevenson W, Pugazhendhi S, Wang M. Is the main lacrimal gland indispensable? Contributions of the corneal and conjunctival epithelia. Surv Ophthalmol. 2016;61(5):616e27 Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016; 4(4):e1251384.

      Su T, Liu R, Lee A, et al. Altered Intestinal Microbiota with Increased Abundance of Prevotella Is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterol Res Pract. 2018; 2018:6961783 Sullivan DA, Dana R, Sullivan RM, Krenzer KL, Sahin A, Arica B, Liu Y, Kam WR, Papas AS, Cermak JM. Meibomian Gland Dysfunction in Primary and Secondary Sjögren Syndrome. Ophthalmic Res. 2018;59(4):193e205 .

      Szymula A, Rosenthal J, Szczerba BM, Bagavant H, Fu SM, Deshmukh US. T cell epitope mimicry between Sjögren’s syndrome antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol 2014; 152:1–9.

      Takahashi H, Asano K, Nakamura S, Ishida-Yamamoto A, Iizuka H. Interferon-gamma-dependent stimulation of human involucrin gene expression: STAT1 (signal transduction and activators of transcription 1) protein activates involucrin promoter activity. Biochem J. 1999 Dec 15;344 Pt 3(Pt 3):797-802. PMID: 10585866; PMCID: PMC1220701.

      Tamanai-Shacoori Z, Smida I, Bousarghin L, et al. Roseburia spp.: a marker of health? Future Microbiol 2017; 12: 157-70.

      Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44:93.

      Theander E, Henriksson G, Ljungberg O, et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006; 65:796.

      Thorne I, Sutcliffe N, Sjögren`s Syndrome. Br J Hosp Med (Lond) 2017 Aug 2;78(8):438-442. doi: 10.12968/hmed.2017.78.8.438 Torrente-Segarra V, Corominas H, Sánchez-Piedra C, et al. Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER). Clin Exp Rheumatol 2017; 35 Suppl 105:28.

      Tsubota K, Xu KP, Fujihara T, Katagiri S, Takeuchi T. Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands. J Rheumatol. 1996;23(2):313e20 Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999; 83:390.

      Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE et al. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480–484.

      Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009; 9(11):799-809.

      Tzamalis A, Matsou A, Anastasopoulos E, Ziakas N. Treatment of spontaneous corneal perforation secondary to undiagnosed Sjögren's syndrome using regenerating agent and autologous serum eye drops. Eur J Ophthalmol. 2021 Jan;31(1):NP17-NP21. doi: 10.1177/1120672119853106. Epub 2019 May 29. PMID: 31137968.

      Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends in Immunology September 2012; 33(9):459-66 Ulff-Moller CJ, Svendsen AJ, Viemose LN, Jacobsen S. Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort. Semin Arthritis Rheum 2018; 47: 538–44.

      Vaarala O, Atkinson MA, Neu J: The ‘‘perfect storm’’ for type 1 diabetes - the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 57:2555–2562.

      Vaishnava S, Behrendt CS, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. U.S.A. 2008; 105, 20858–20863 Van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969 Jul;82(1):10-4. doi: 10.1001/archopht.1969.00990020012003. PMID: 4183019.

      Van der Meulen, HJM Harmsen, H Bootsma, FKL Spijkervet, FGM Kroese, A Vissink. INVITED MEDICAL REVIEW.
The microbiome–systemic diseases connection. Oral Diseases 2016; Van der Meulen TA, Harmsen HJM, Bootsma H, Liefers SC, Vila AV, Zhernakova A, Fu J, Wijmenga C, Spijkervet FKL, Kroese FGS, Vissink A. Dysbiosis of the buccal mucosa microbiome in primary Sjögren’s syndrome patients. Rheumatology (Oxford) 2018; 57: 2225–34.

      Van der Meulen TA, Harmsen HJM, Bootsma H, Liefers SC, Vila AV, Zhernakova A, Weersma RK, Spijkervet FKL, Kroese FGS, Vissink A. Reduced salivary secretion contributes more to changes in the oral microbiome of patients with primary Sjögren’s syndrome than underlying disease. Ann Rheum Dis 2018; 77: 1542–4. BIS Van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A, Fu J, Wijmenga C, Weersma RK, de Leeuw K, Bootsma H, Spijkervet FKL, Vissink A, Kroese FGM. Shared gut, but distinct oral microbiota composition in primary Sjögren’s syndrome and systemic lupus erythematosus. J Autoimmun 2019; 97: 77–87.

      Van der Meulen TA, van Nimwegen JF, Harmsen HJM, Liefers SC, van der Tuuk K, Kroese FGM, Mourits MJE, Vissink A, Bootsma H. Normal vaginal microbiome in women with primary Sjögren’s syndrome-associated vaginal dryness. Ann Rheum Dis 2019; 78: 707–9. BIS Van der Worp E, Bornman D, Ferreira DL, et al. Modern scleral contact lenses: A review. Cont Lens Anterior Eye 2014; 37:240.

      Van Nimwegen JF, Mossel E, Delli K, van Ginkel MS, Stel AJ, Kroese FGM, Spijkervet FKL, Vissink A, Arends S, Bootsma H. Incorporation of Salivary Gland Ultrasonography Into the American College of Rheumatology/European League Against Rheumatism Criteria for Primary Sjögren's Syndrome. Arthritis Care Res (Hoboken). 2020 Apr;72(4):583-590. doi: 10.1002/acr.24017. PMID: 31254454; PMCID: PMC7155092.

      Varela-Centelles P, Sanchez-Sanchez M, Seoane J. Lip biopsy for the diagnosis of Sjögren's syndrome: beware of the punch. Int J Oral Maxillofac Surg. 2014 Jan;43(1):127-30. doi: 10.1016/j.ijom.2013.05.014. Epub 2013 Jul 6. PMID: 23838523.

      Verstappen GM, Corneth OBJ, Bootsma H, Kroese FGM. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity. J Autoimmun. 2018 Feb;87:16-25. doi: 10.1016/j.jaut.2017.11.003. Epub 2017 Nov 27. PMID: 29191572.

      Villani E, Magnani F, Viola F, Santaniello A, Scorza R, Nucci P, Ratiglia R. In vivo confocal evaluation of the ocular surface morpho-functional unit in dry eye. Optom Vis Sci. 2013;90(6):576e86 Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, and the European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-8 Vrabec MP, Elsing SH, Aitken PA. A prospective, randomized comparison of thermal cautery and argon laser for permanent punctal occlusion. Am J Ophthalmol 1993; 116:469.

      Wang C, Zaheer M, Bian F, Quach D, Swennes AG, Britton RA, Pflugfelder SC, de Paiva CS. Sjögren-Like Lacrimal Keratoconjunctivitis in Germ-Free Mice. Int J Mol Sci. 2018 Feb 13;19(2):565. doi: 10.3390/ijms19020565. PMID: 29438346; PMCID: PMC5855787.

      Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000;113 Pt 24:4435-40.

      Warner BM, Baer AN, Lipson EJ, et al. Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy. Oncologist 2019; 24:1259.

      West CE, Renz H, Jenmalm MC, Kozyrskyj AL, Allen KJ, Vuillermin P, Prescott SL; in-FLAME Microbiome Interest Group. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immunol 2015; 135(1):3–13.

      Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara NA, Greenspan JS, Daniels TE; Sjögren's International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. Am J Ophthalmol. 2010 Mar;149(3):405-15. doi: 10.1016/j.ajo.2009.09.013. Epub 2009 Dec 29. PMID: 20035924; PMCID: PMC3459675.

      Willis J.R., Gabaldón T. The Human Oral Microbiome in Health and Disease: From Sequences to Ecosystems. Microorganisms. 2020;8:308 Winslet MC, Poxon V, Allan A, et al. Mucosal glucosamine synthetase activity in inflammatory bowel disease. Dig Dis Sci 1994;39(3):540-4).

      Wu H-J, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D. Gut-residing segmented lamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32:815–27.

      Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427-434 Xu M, Jiang Y, Wang J, Liu D, Wang S, Yi H, Yang S. Distribution of distinct subsets of circulating T 
follicular helper cells in Kawasaki disease, BMC Pediatrics 2019; 19(1) Yamamoto EA, Jørgensen TN. Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Front Immunol. 2020 Jan 21;10:3141. doi: 10.3389/fimmu.2019.03141. PMID: 32038645; PMCID: PMC6985452.

      Yasunaga H, Takeshita T, Shibata Y, Furuta M, Shimazaki Y, Akifusa S, et al. Exploration of bacterial species associated with the salivary microbiome of individuals with a low susceptibility to dental caries.Clin Oral Investig. 2017; 21: 2399–2406. https://doi.org/10.1007/s00784-016-2035-5 PMID: 28013437 Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol 2007; 144:86.

      Youinou P, Pers JO. Disturbance of cytokine networks in Sjögren's syndrome. Arthritis Res Ther. 2011 Jul 6;13(4):227. doi: 10.1186/ar3348. PMID: 21745420; PMCID: PMC3239335.

      Yoshimoto K, Tanaka M, Kojima M, Setoyama Y, Kameda H, Suzuki K, Tsuzaka K, Ogawa Y, Tsubota K, Abe T, Takeuchi T. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome. Arthritis Res Ther. 2011;13(5):R170. doi: 10.1186/ar3493. Epub 2011 Oct 21. PMID: 22018243; PMCID: PMC3308105.

      Zaheer M, Wang C, Bian F, Yu Z, Hernandez H, de Souza RG, Simmons KT, Schady D, Swennes AG, Pflugfelder SC, Britton RA, de Paiva CS. Protective role of commensal bacteria in Sjögren Syndrome. J Autoimmun. 2018;Sep;93:45-56. doi: 10.1016/j.jaut.2018.06.004. Epub 2018 Jun 20.

      Zaneveld, J.*; Caporaso, J. G.; McDonald, D.; Knights, D.; a Reyes, J.; Clemente, J. C.; Burkepile, D. E.; Vega Thurber, R. L.; Knight, R.; Beiko, R. G.; and Huttenhower, C. Nature Biotechnology, 1-10. 8 2013.).

      Zhang X, Chen W, De Paiva CS, Corrales RM, Volpe EA, McClellan AJ, Farley WJ, Li DQ, Pflugfelder SC. Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci. 2011 Aug 9;52(9):6279-85. doi: 10.1167/iovs.10-7081. PMID: 21474767; PMCID: PMC3176027.

      Zhong D, Wu C, Zeng X, Wang Q. The role of gut microbiota in the pathogenesis of rheumatic diseases. Clin Rheumatol. 2018;37(1):25–34.

      Zhou Z, Ling G, Ding N, Xun Z, Zhu C, Hua H, et al. Molecular analysis of oral microflora in patients with primary Sjögren’s syndrome by using high-throughput sequencing. PeerJ. 2018; 6: e5649. https://doi.org/10.7717/peerj.5649 PMID: 30280027 Zou Y, Xue W, Luo G, Deng Z, Qin P, Guo R, et al. 1,520 reference genomes from cultivated human gut bacteria enable functional micr


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno